https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png217230Sakina/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngSakina2025-03-20 13:18:522025-03-25 13:20:0020/03/25 – UNITE4TB welcomes the ENABLE study to its growing clinical trial portfolio.
https://amr-accelerator.eu/wp-content/uploads/2024/11/Circle_RespiriTB-1.png217230Sakina/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngSakina2025-03-15 13:16:112025-03-25 13:18:1615/03/25 – RespiriTB Annual General Assembly in Vienna
https://amr-accelerator.eu/wp-content/uploads/2022/02/primavera-1.png217230Sakina/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngSakina2025-03-11 13:09:392025-03-25 13:11:3711/03/25 – PrIMAVeRa presents a video at ESCMID Global 2025
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_ERA4TB.png217230Sakina/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngSakina2025-03-07 13:12:342025-03-25 13:15:0107/03/25 – Celebrating women in TB research
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_COMBINE.png217229Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2025-02-24 17:43:572025-02-26 14:23:3323/02/25 – COMBINE Publication on machine learning model to identify new antibiotics
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png250800Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2024-11-26 18:01:222024-12-13 11:59:03Nasreen Hassoun-Kheir: A Doctor’s Mission to Stop Superbugs
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png250800Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2024-11-21 14:41:582024-12-13 11:58:40Quentin J. Leclerc: Targeting Supercontactors for Safer Long-Term Care
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png250800Sakina/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngSakina2024-09-24 15:25:022025-01-23 15:31:2124/09/2024 Sustaining European Antibiotics Through R&D Funding
https://amr-accelerator.eu/wp-content/uploads/2022/01/Partner_PrIMAVeRa_0000_ares.jpg500500Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2022-07-26 14:06:272023-07-28 14:06:3726/07/22 – OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
https://amr-accelerator.eu/wp-content/uploads/2022/04/NICE.png20002000Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2022-04-12 13:56:112023-07-28 14:54:0512/04/22 – NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance
https://amr-accelerator.eu/wp-content/uploads/2022/03/Uni-Dundee.png20002000Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2022-03-04 14:00:462023-07-28 14:54:4224/03/22 – Post-Covid TB warning as DDU receives $5 million award
https://amr-accelerator.eu/wp-content/uploads/2019/04/LogoSantPau.png756756Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2022-02-01 14:04:192023-07-28 14:04:3401/02/22 – ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner
https://amr-accelerator.eu/wp-content/uploads/2023/07/Uni-Oxford-UCL.png20002000Tolga/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.pngTolga2021-11-02 13:50:102023-07-28 13:50:2102/11/21 – Antibiotic Research UK awards grants to fund research worth £200,000
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Google Webfont Settings:
Vimeo and Youtube video embeds:
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.
Other external services
We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Vimeo and Youtube video embeds:
Privacy Policy
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
AMR Accelerator Newsletter – November 2022
ERA4TB Newsletter – September 2022
UNITE4TB Newsletter – September 2022
RespiriNTM & -TB Newsletter – May 2022
AMR ACCELERATOR NEWSLETTER – MAY 2022
ERA4TB Newsletter – February 2022